
An EMA survey has identified gaps in the pharmaceutical industry’s preparedness for Brexit, finding that only 58% of market authorisation …

The London-based biomedical research charity the Wellcome Trust, Britain’s wealthiest foundation, has announced the launch of a new £250 million …

Trump bared his teeth, and it paid off. Following his call-out of Pfizer after the US pharma giant ignored the …

The Boston-based clinical biotechnology company Syntimmune has appointed Dr Mario Saltarelli as its Chief Medical Officer. Dr Saltarelli will take …

India and China have reached an agreement aimed at reducing tariffs on Indian pharmaceuticals going between the world’s two most …

Several drugs designed for the treatment of high blood pressure and heart conditions have been recalled across Europe over fears …

Sanofi announced yesterday that they have stopped production at their plant in the French Pyrenees following complaints that the factory …

NICE have published a draft antimicrobial prescribing guide recommending that healthcare professionals should consider the risk of antimicrobial resistance when …

Price hiking in the pharmaceutical industry continues to persist, and has become ever more prominent in the public sphere thanks …

New Jersey-based multinational MSD have announced that the European Commission (EC) has approved Simponi (golimumab) for early dose optimisation in …

The Japan-based Eisai and Massachusetts-based Biogen have announced that experimental drug BAN2401 has demonstrated efficacy in slowing the progression of …

New evidence published in the British Journal of Surgery has indicated a troubling link between long-term use of the breast …

Jean-Yves Brault, Country Manager at Mylan UK, discusses how biosimilars are going to play an important role in driving down …

The Scottish Medicines Consortium has approved the use of EUSA Pharma’s Fotivda (tivozanib) as a first-line treatment for people with …

California-based biotech Regulus Therapeutics has announced it is to strip away more than half of its total workforce as part …

As the Israeli firm presses on with attempts to cut back on costs and streamline operations, Teva has announced plans …

As the first week of July comes to an end we take a look over the most popular stories of …

As public focus on the issue of medicinal cannabis continues to grow, Zynerba Pharmaceuticals has announced that its transdermal tetrahydrocannabinol …

A $55 million verdict against the multinational pharmaceutical company Johnson & Johnson has been overturned by an appeals court in …

Illicit forms of the powerful opioid fentanyl have been driving increased rates of opioid-related deaths in the Canadian province of …